Missouri will receive nearly $14 million, as part of a settlement of a multi-state lawsuit against drug manufacturer Merck.
The lawsuit centers on the prescription drug Vioxx, which the company marketed as a painkiller for people diagnosed with Rheumatoid Arthritis. Merck has agreed to plead guilty to a misdemeanor for promoting the drug before receiving FDA approval, and it will pay $950 million in criminal and civil penalties. The company halted sales of Vioxx in 2004 after evidence showed the drug doubled the risk of heart attack and stroke.